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Objectives. This study sought to investigate changes in myocar-
dial perfusion after direct percutaneous transluminal coronary
angioplasty (PTCA) in acute myocardial infarction (MI).
Background. After initially successful recanalization of the
infarct-related artery, coronary perfusion may deteriorate as a
result of reocclusion, distal embolization of platelet aggregates
formed at the dilated plaque or microvascular reperfusion injury.
This change could offset the benefit from early intervention.
Methods. The study included 19 patients in whom the infarct-
related artery was successfully recanalized by PTCA with Palmaz-
Schatz stent placement within 24 h after the onset of pain. Basal
and papaverine-induced coronary blood flow were assessed by
Doppler flow velocity measurements and quantitative coronary
angiography. In addition, basal and adenosine-induced myocar-
dial blood flow were measured by nitrogen-13 ammonia positron
emission tomography (PET).
Results. Immediately after completion of the intervention, the
average coronary flow reserve (CR) in the recanalized vessel was
1.56 6 0.51; it increased to 2.04 6 0.65 at 1 h (p 5 0.013) and to
2.66 6 0.72 at 2 weeks after reperfusion (p 5 0.008, n 5 16). PET
studies in 12 patients revealed that perfusion defect size and CR
in the infarct region (2.19 6 0.89 vs. 2.33 6 0.86) did not change
significantly between day 2 after recanalization and 2 weeks.
However, we found significant (p < 0.03) increases in basal (by
26%) and adenosine-induced (by 40%) blood flow in the infarct
region.
Conclusions. Despite the persistence of a perfusion defect after
successful recanalization of the occluded artery in acute MI, CR of
the infarct region improves in most patients within 1 h and
further improves within 2 weeks.
(J Am Coll Cardiol 1997;30:1270–6)
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Recanalization of the occluded coronary artery in acute myo-
cardial infarction (MI) does not afford a substantial clinical
benefit if coronary blood flow continues to be compromised
(1). After thrombolysis, residual stenoses are the most obvious
cause for depressed coronary blood flow after recanalization of
the infarct-related artery. Direct percutaneous transluminal
coronary angioplasty (PTCA) as the therapeutic approach in
acute MI minimizes the residual stenosis after recanalization
(2,3), and the angiographic result may be further improved by
adjunctive stent placement (4).
However, postischemic microvascular incompetence may
still compromise myocardial blood flow after direct PTCA in
acute MI (5–8). Myocardial perfusion may even deteriorate
further during the early reperfusion period because of partial
reocclusion of the infarct-related artery, distal embolization of
platelet aggregates formed at the dilated plaque, or microvas-
cular reperfusion injury due to cardiac inflammatory responses
(9–15).
To address this question, we examined patients with acute
MI undergoing successful direct PTCA with adjunctive stent-
ing and serially measured Doppler flow velocity in the infarct-
related artery to assess changes in coronary blood flow during
the 1st h and at 2 weeks after reperfusion. In addition, we
performed perfusion imaging by positron emission tomogra-
phy (PET) 24 to 72 h and 2 weeks after direct PTCA.
Methods
Patient selection. The study included 19 patients with
acute MI who were successfully treated by direct PTCA. All
patients had presented within 24 h after the onset of pain. The
indication for intervention in patients presenting .12 h after
the onset of pain was persistent angina. We did not include 1)
patients with residual anterograde flow or angiographically
visible collateral blood supply of the distal infarct-related
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coronary artery, 2) patients who were in hemodynamically
unstable condition (systolic blood pressure ,100 mm Hg) or
who had substantial pulmonary congestion (rales more than
halfway up the lung fields), or 3) patients with previous MI.
Tables 1 and 2 show the baseline clinical, angiographic and
hemodynamic characteristics of the study patients. Patients
with interfering noncardiac diseases, such as inflammatory
disorders, malignant neoplasm or infection, were not eligible
for the study. The study was approved by the institutional
ethics committee for human subjects. Written informed con-
sent was obtained from all patients.
Interventional procedures and postinterventional manage-
ment. Before the study, all patients with acute MI had been
given intravenous bolus injections of heparin (5,000 IU),
aspirin (1 g), metoprolol (5 mg, 1 to 3 times), and morphine
(5 mg, 1 to 2 times), depending on individual response. Before
coronary angiography an additional dose of heparin (10,000
IU) was given intraarterially. PTCA and Palmaz-Schatz stent
placement (Johnson&Johnson Interventional Systems) were
performed as described earlier (4,16).
After the intervention, seven patients received the vitamin
K antagonist phenprocoumon (Marcumar, Hoffmann-La
Roche, Grenzach-Wyhlen, Germany) and overlapping intrave-
nous heparin. In addition, these patients were treated with
aspirin (100 mg twice daily). Due to changing concepts of
antithrombotic therapy after coronary stenting (17), 12 pa-
tients received combined antiplatelet therapy with ticlopidine
(2 3 250 mg) plus aspirin (2 3 100 mg) instead of anticoagu-
lant agents. Post-MI surveillance included repeated electrocar-
diographic (ECG) recordings and serial creatine kinase (CK)
measurements. In all study patients, we administered
angiotensin-converting enzyme inhibitors and beta-blocking
agents.
Study protocol. Immediately after completion of stent
placement and 1 h after the initial reperfusion, we performed
blood flow velocity measurements in the infarct-related coro-
nary artery and quantitative coronary angiography (QCA).
Thereafter, we determined blood velocities in the least dis-
eased coronary artery, which served as a control vessel. Finally,
we measured left ventricular (LV) end-diastolic pressure
through a pig-tail catheter and obtained a left ventriculogram.
Perfusion imaging by PET was performed in 12 patients 24 to
72 h after reperfusion. Patients were followed up at 2 weeks
after the intervention. We performed QCA and single-plane
ventriculography and repeated the flow velocity measurements
in the infarct-related artery and the control vessel; final PET
studies were scheduled the day after these studies.
Quantitative angiography. Coronary angiography and
single-plane left ventriculography in the 30° right anterior
oblique view were performed with a digital angiography system
and images were stored on digital tapes (Hicor, Siemens,
Erlangen, Germany). Angiograms were analyzed off-line on a
digital angiographic work station (AWOS, Siemens). Auto-
matic edge detection enabled absolute measurement of coro-
nary diameters (16,17). Global LV ejection fraction (EF) was
determined by using the area-length method (18). To quantify
regional LV wall motion we used the centerline method (19).
Within the region of interest, the mean wall motion of one half
of the most abnormally contracting contiguous chords was
determined to yield the wall motion index of that region (19).
This result was expressed in standard deviation (from normal)
per chord (SD/chord). In addition, we determined the number
of chords within the region of interest showing hypokinesia
$21 SD.
Coronary flow velocity measurements. Coronary flow ve-
locities were measured with the 0.014 in. (0.036 cm) floppy
Doppler wire (FloWire, Cardiometrics) and analyzed by the
FloMap system (Cardiometrics), as described and validated by
Doucette et al. (20).
After completion of PTCA and stent placement we ex-
changed the angioplasty guide wire for the Doppler wire. By
Table 1. Baseline Characteristics of 19 Study Patients
Male/female ratio 14/5
Age (yr) 59.0 6 10
Range 37 to 83
Active smokers 7 (36.8%)
Hypercholesterolemia 13 (68.4%)
Systemic hypertension 9 (47.4%)




Calcium channel antagonists 2 (10.5%)
Nitrates 3 (15.8%)
ACE inhibitors 2 (10.5%)






Left anterior descending 11 (57.9%)
Left circumflex 2 (10.5%)
Right 6 (31.6%)
Peak creatine kinase concentration (U/liter) 1,502 6 1,091
Hours from pain to intervention (median; quartiles) 4; 3,8
Unless otherwise indicated, data presented are mean value 6 SD or number
(%) of patients. ACE 5 angiotensin-converting enzyme; CAD 5 coronary artery
disease.
Abbreviations and Acronyms
APV 5 averaged peak velocity
CK 5 creatine kinase
CR 5 coronary flow reserve
ECG 5 electrocardiogram, electrocardiographic
EF 5 ejection fraction
LV 5 left ventricular
MI 5 myocardial infarction
PET 5 positron emission tomography
PTCA 5 percutaneous transluminal coronary angioplasty
QCA 5 quantitative coronary angiography
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placing its tip just proximal to the site of recanalization, we
ensured that the sampling volume corresponded to the site of
occlusion, thus assessing flow to the entire area at risk. In one
patient, in whom occlusion had occurred immediately distal to
a patent side branch, we advanced the tip of the Doppler wire
just beyond the branching point.
Doppler flow velocity spectra were analyzed on-line to
determine time-averaged peak velocity (APV), and ECG as
well as blood pressure were monitored continuously. To de-
termine coronary flow reserve (CR), we gave intracoronary
bolus doses of papaverine (10 mg). Before the next measure-
ment, we waited until APV had returned to baseline. Basal and
maximal APV after intracoronary papaverine were docu-
mented by video printout. Immediately after each measure-
ment of basal or maximal APV we performed QCA for
assessment of residual stenosis and of vessel diameter (D)
within the sample volume, that is, 5 mm distal to tip of the
Doppler wire. Doppler-derived flow (Q) was calculated as (20)
Q 5 ~0.5 3 APV! 3 ~pD2!/4.
Intracoronary papaverine induced a variable decrease in
mean aortic pressure by 3.4 6 8.1%. We therefore calculated
CR as the ratio of peak flow after papaverine (Qp) and basal
flow (Qb) with adjustments for differences between basal mean
arterial pressure (MAPb) and mean arterial pressure at peak
flow (MAPp), thus obtaining:
CR 5 ~Qp/Qb! 3 ~MAPb/MAPp!.
PET studies. Perfusion imaging with N-13 ammonia was
performed as described previously (21,22), using an ECAT
951R/31 (Siemens) whole body scanner. After the transmission
data acquisition, 20 mCi of N-13 ammonia was injected
intravenously and PET acquisition was initiated (12 3 10 s, 6 3
30 s, 3 3 300 s). After a further period of 30 min, adenosine
(0.14 mg/kg per min) was infused intravenously for 5 min. At
the 2-min mark of this infusion, a second injection of 20 mCi of
N-13 ammonia was administered and PET acquisition was
repeated.
Image data were analyzed by using short-axis images.
Myocardial region of interest was defined on the basis of rest
perfusion abnormalities. In addition, a region of interest was
placed over remote myocardium to obtain reference informa-
tion. The ratio of maximal flow to rest flow is the myocardial
flow reserve. The extension of perfusion defects was deter-
mined by comparing regional relative tracer uptake with
control data obtained in healthy volunteers using the polar
map approach and a threshold of 2.5 SD.
Statistical analysis. Results are reported as mean value 6
SD, unless otherwise indicated. The Kolmogorov-Smirnov test
showed that the perfusion data were not normally distributed.
Analyzing the perfusion data, differences between two
matched samples by Wilcoxon matched pairs signed rank test
and those between more than two matched samples were
tested by the Friedman test followed by Wilcoxon matched
pairs signed rank test. Otherwise, differences were analyzed by
analysis of variance followed by the Scheffe´ test or by paired t
test, as appropriate. Linear regressions were calculated by the
least square method. A p value ,0.05 in the two-tailed test was
regarded as significant.
Results
Direct PTCA with stent placement was successfully com-
pleted in all patients, resulting in minimal residual stenosis
(Table 2). In all patients the angiographic result was stable
throughout the study period (Table 2), and there was no
clinical, ECG or enzymatic evidence of infarct extension.
Within 2 weeks extent of hypokinesia and wall motion index of
the infarct region improved significantly and LV end-diastolic
pressure decreased significantly (Table 2). Moreover, diastolic
blood pressure and pulse rate at follow-up were slightly but
significantly lower than in the initial study.
Two patients with an uncomplicated clinical course refused
angiographic follow-up and in one diabetic patient we did not
perform angiographic follow-up because of a temporary rise in
serum creatinine after direct PTCA. Twelve of the 16 patients










Reference diameter (mm) 3.16 6 0.44* 3.30 6 0.42 3.26 6 0.43 0.005
Minimal lumen diameter (mm) 2.97 6 0.45 3.08 6 0.54 3.01 6 0.40 0.071
Diameter stenosis (%) 6.09 6 5.92 6.51 6 6.20 5.79 6 7.51 0.77
Global LV EF (%) n.d. 51.92 6 213.15 57.15 6 217.66 0.23
Severity of infarct-related wall motion
abnormality (SD/chords)
n.d. 22.61 6 1.41 21.50 6 1.50 0.003
Infarct area with 21 SD hypokinesia (chords) n.d. 37.25 6 220.38 25.88 6 222.32 0.012
Systolic blood pressure (mm Hg) 113.05 6 20.87 118.0 6 21.3 107.06 6 16.89 0.28
Diastolic blood pressure (mm Hg) 75.42 6 11.01 76.2 6 11 65.2 6 10.1* 0.001
Pulse rate (beats/min) 81.11 6 13.47 81.84 6 14.51 72 6 15.11* 0.021
LV EDP (mm Hg) n.d. 24.21 6 8.56 16.88 6 5.60 0.001
*Significantly different (p , 0.05) from the two other measurements. Data presented are mean value 6 SD. EDP 5
end-diastolic pressure; EF 5 ejection fraction; LV 5 left ventricular; n.d. 5 not determined.
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who completed the angiographic and Doppler wire studies
consented to have both PET studies.
Coronary blood flow. After completion of PTCA and stent-
ing, the first Doppler flow velocity measurements were ob-
tained at 21 6 8 min after reperfusion. Between this time and
1 h after reperfusion, basal blood flow in the infarct-related
artery did not change significantly (Fig. 1a), whereas the
papaverine-induced flow increased significantly (Fig. 1b). On
average, CR in the infarct-related coronary artery increased
significantly during the 1st h of reperfusion (Fig. 1c).
Six patients showed an early decrease in CR. These patients
tended to have a higher peak CK concentration than the
others. Changes in Doppler flow CR in the infarct-related
artery within the 1st h of reperfusion showed a significant
inverse correlation to peak CK concentration but were not
related to the time between onset of pain and intervention
(Fig. 2). There were no significant (p . 0.3) differences in
contractile recovery between patients with an early decrease
and an early increase in CR, as assessed by the decrease either
in number of chords with hypokinesia (12.9 6 17.6 vs. 8.8 6
13.6) or in severity of wall motion abnormality (1.33 6 1.41 vs.
0.73 6 0.92). Nor did we find a significant relation between
early changes in CR and subsequent change in either number
of chords with hypokinesia (r 5 20.10, p 5 0.71) or severity of
wall motion abnormality (r 5 20.09, p 5 0.74).
We performed angiographic follow-up 14.4 6 2.8 days after
the initial study. Between 1 h after reperfusion and follow-up,
mean CR in the infarct-related artery showed significant
further improvement (Fig. 3), which could be attributed to a
significant increase in papaverine-induced flow (Fig. 3). At
follow-up, CR correlated with the extent of regional LV
dysfunction, as assessed by the number of chords with hypoki-
nesia (r 5 20.52, p 5 0.038) and the wall motion index (r 5
0.69, p 5 0.003).
In the control vessels, average CR was 2.27 6 0.80 at 1 h
after reperfusion and did not change significantly until
follow-up at day 14 (2.48 6 0.93).
Perfusion imaging. The first PET study was performed
41 6 21 h after recanalization of the infarct-related artery and
the second 16.3 6 3.3 days after the intervention. Sizes of the
perfusion defects, both under rest conditions and after aden-
osine infusion, did not differ significantly (p . 0.5) between the
two PET studies (rest perfusion defect [% of LV circumfer-
ence]: 25 6 23% vs. 26 6 95%, p 5 0.72; adenosine-induced
perfusion defect: 24 6 23% vs. 27 6 21%, p 5 0.52).
Moreover, in both perfusion studies, sizes of the rest and
adenosine-induced perfusion defects did not differ significantly
(p . 0.67). Adenosine-induced perfusion defect sizes on day 2
correlated with global LV EF (r 5 20.89, p 5 0.001), number
of chords with hypokinesia (Fig. 4) and wall motion index (r 5
20.66, p 5 0.020) at follow-up.
Between the two PET studies, we found a significant
increase in adenosine-induced blood flow in the infarct region
(Fig. 5b). Due to a concomitant increase in basal blood flow in
the infarct region (Fig. 5a), we did not find significant changes
in infarct region CR between the two PET studies (Fig. 5c).
CR values, determined by PET and Doppler wire at
follow-up day 2, did not differ significantly (p 5 0.26). In the
PET studies, average CR of the control regions did not change
Figure 1. Plot of changes in basal coronary flow (panel a), papaverine-
induced coronary flow (panel b) and CR (panel c) in the infarct-
related artery within the 1st h of reperfusion as assessed by Doppler
wire in 19 patients. Mean values (circles) 6 SD (vertical bars) are also
shown; p values indicate level of significance for difference between t1
min and 1 h after reperfusion. t1 5 immediately after completion of
PTCA and stenting (21 6 8 min after initial recanalization).
Figure 2. Plot of changes in CR between 21 min and 1 h after
reperfusion, as assessed by Doppler wire measurements in 19 patients
as a function of peak CK concentration (left panel) and as a function
of time from the onset of pain to reperfusion (right panel). Regression
lines, regression coefficients r and p values of the linear regression are
also shown.
Figure 3. Plot of changes in basal coronary flow (panel a), papaverine-
induced coronary flow (panel b) and CR (panel c) in the infarct-
related artery between 1 h and 14 days after reperfusion, as assessed by
Doppler wire measurements in 16 patients. Mean values (squares) 6
SD (vertical bars) are also shown. p values indicate level of signifi-
cance for difference between 1 h and 14 days after reperfusion.
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significantly during the study period (2.78 6 1.63 vs. 2.53 6
0.95, p 5 0.89).
Discussion
We investigated changes in CR after successful recanaliza-
tion of the infarct-related coronary artery by direct PTCA with
Palmaz-Schatz stent implantation. Our major finding was early
and sustained recovery of CR as the prevailing feature after
successful catheter intervention. Within 1 h of reperfusion,
average CR in the recanalized infarct-related artery increased
from 1.5 to just .2, and during the subsequent 14 days
improved further to 2.6. This change in CR is driven by an
increase in papaverine-induced blood flow and not by a
decrease in basal flow. Our findings thus indicate substantial
recovery of flow capacity within the reperfused area or exten-
sion of the area with relevant reperfusion, or both. At follow-
up, both perfusion imaging and Doppler measurements
showed CR values that were not significantly different from
those in the control region. Most of the recovery beyond 1 h
appears to occur during the 1st 2 days. This view is suggested
by the results of perfusion imaging, demonstrating no substan-
tial changes in CR of the infarct region or in perfusion defect
sizes between day 2 and follow-up.
Despite this remarkable recovery of CR, perfusion imaging
demonstrated depressed absolute flows within the infarct
region. Previous studies in canine MI (23,24) showed pre-
served flow in the subepicardial layers and depressed flow in
the subendocardial layers during reperfusion. Similarly, our
results may be explained by the coincidence of regions with no
or low reflow and regions with rapid recovery of flow reserve
and eventual near normal flow. Accordingly, extension of the
layer with near normal flow may account for the increases in
basal and adenosine-induced myocardial blood flow between
day 2 and follow-up (25,26). The spatial resolution of the PET
technique may not suffice to verify such inhomogeneities of
microvascular flow within the infarct region.
Perfusion patterns could be related to variables of regional
LV function. CR in the infarct-related artery at follow-up
correlated with concomitantly determined measures of infarct
size and severity of wall motion abnormality. Moreover, per-
fusion defect sizes at day 2 correlated with ventriculographic
measures of infarct size at follow-up. These findings support
the concept that recovery of vascular function within the area
at risk is spatially linked to viable myocardium (25,26).
In six patients, the prevailing pattern of early changes in CR
deviated. In these patients we found a decrease in CR within
1 h of reperfusion, which may be interpreted as evidence of
reperfusion injury. Patients with an early decrease in CR
tended to have larger infarcts than the other patients, and early
recovery of CR was inversely correlated to peak CK concen-
tration. Early deterioration in CR did not have a detectable
impact on functional recovery of the infarct region. These
findings may be explained by assuming that early deterioration
in CR is due to collapse of perfusion capacity within an area of
irreversibly damaged myocardium (25,26).
Comparison with previous studies. Since the initial de-
scription of ischemic microvascular injury, commonly referred
to as the “no reflow phenomenon” (27), several studies in the
dog model (12–14) have provided evidence of microvascular
reperfusion injury. These studies demonstrated progressive
deterioration of myocardial blood flow (12,13) and flow re-
serve (14), assessed by tracer microspheres (12–14) or PET
(13), as well as progressive perfusion defects demonstrated by
fluorescent dyes (12) or perfusion imaging (14). These changes
occurred as early as 1 h after perfusion (12,13). Contrary to
these findings in the dog, myocardial perfusion did not dete-
riorate within the 1st h of reperfusion in most of our patients.
Several factors may account for this difference. In animals,
substantial extension of tissue injury during reperfusion has
not been observed after periods of ischemia .120 to 180 min
(5). However, reflecting the usual clinical setting, the duration
of ischemia in our patients was .180 min. It thus may not fall
into the time window during which reperfusion injury can
occur. Moreover, to an unknown extent, the adjunctive phar-
macologic interventions, such as administration of aspirin,
Figure 4. Plot of number of chords with hypokinesia ($21 SD) at
follow-up as a function of adenosine-induced perfusion defect sizes at
day 2 as assessed by PET in 11 patients. Regression line, regression
coefficient r and p value of the linear regression are also shown.
Figure 5. Plot of changes in basal myocardial blood flow (panel a),
adenosine-induced myocardial blood flow (panel b) and CR (panel c)
in the infarct region between day (d) 2 and day 16 after reperfusion, as
assessed by PET studies in 12 patients. Mean value (circles) 6 SD
(vertical bars) are also shown. p values indicate level of significance for
difference between day 2 and day 16 after reperfusion.
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heparin and morphine, may have helped to prevent reperfu-
sion injury.
To our knowledge, changes in coronary blood flow within
1 h of reperfusion have not been previously investigated in
patients with MI. Several clinical studies (7,8,28,29) investi-
gated subacute changes in myocardial blood flow after reper-
fusion in MI, but these studies included patients who had
undergone thrombolysis without definition of degree of resid-
ual stenosis. After thrombolysis, early deterioration of blood
flow appears to be considerably more frequent than with
minimal residual stenosis and a stable angiographic result, as in
our study (8). Moreover, one previous study (28) reported
substantially lower CR in the infarct region than that of our
patients, a finding that must be attributed to the high degree of
residual stenosis after thrombolysis (28,30). Nevertheless, two
previous studies (7,31) also found improvement of myocardial
blood flow in the infarct region within 2 or 4 weeks after
reperfusion. Similar to our study, the extent of early perfusion
defects, assessed by myocardial contrast echocardiography,
was predictive of subsequent functional recovery (31).
Limitations of the study. Apart from microvascular func-
tion, myocardial blood flow is affected by heart rate and
loading conditions. Although we have no reason to assume that
hemodynamic conditions changed significantly within the 1st h
of reperfusion, there were significant decreases in LV end-
diastolic pressure, pulse rate and diastolic blood pressure
between the initial study and follow-up. To an unknown extent,
these changes may have affected changes in coronary flow
during the study period.
Conclusions and clinical implications. To our knowledge
this study provides first evidence of early and sustained im-
provement of CR in the infarct region after meticulous opti-
mization of vessel patency. It shows that in areas of the infarct
region with salvaged microcirculation further recovery of cor-
onary perfusion can be expected during the early period after
MI. This perfusion pattern is consistent with postischemic
vascular stunning that gradually resolves (31,32). The study
does not refute the concept of microvascular reperfusion
injury, but it does not yield any evidence of its relevance in the
clinical setting. In the minority of our patients with an early
decrease in pharmacologic CR, functional recovery of viable
myocardium was not impaired by comparison with that of the
other patients. Consistent with earlier histologic studies
(25,26), it is therefore tempting to speculate that relevant
deterioration of vascular function during reperfusion does not
occur within areas of viable myocardium. The findings of our
study suggest that the clinical impact of microvascular reper-
fusion injury and no reflow may be less than what might have
been expected on the basis of previous animal experiments
(12–14).
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